Literature DB >> 9111560

Combined radiotherapy and chemotherapy for anal cancer. EORTC Radiotherapy and Gastrointestinal Cooperative Groups.

J F Bosset, J J Pavy, F Roelofsen, H Bartelink.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9111560     DOI: 10.1016/s0140-6736(97)26003-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  [Concomitant radiochemotherapy is superior to radiotherapy alone in the treatment of anal cancer: results of a randomized phase iii study].

Authors:  G G Grabenbauer
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

Review 2.  Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.

Authors:  Wade T Iams; Victoria M Villaflor
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

3.  Local excision for patients with stage I anal canal squamous cell carcinoma can be curative.

Authors:  Sakti Chakrabarti; Zhaohui Jin; Brandon M Huffman; Siddhartha Yadav; Rondell P Graham; Dora M Lam-Himlin; Amy L Lightner; Christopher L Hallemeier; Amit Mahipal
Journal:  J Gastrointest Oncol       Date:  2019-04

4.  A population-based analysis of chemoradiation versus radiation alone in the definitive treatment of patients with stage I-II squamous cell carcinoma of the anus.

Authors:  Jacob S Parzen; Aleksander Vayntraub; Bryan Squires; Muayad F Almahariq; Andrew B Thompson; John M Robertson; Peyman Kabolizadeh; Thomas J Quinn
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 5.  De-Escalation of Therapy for Patients with Early-Stage Squamous Cell Carcinoma of the Anus.

Authors:  Eric Miller; Jose Bazan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.

Authors:  Rohit Kochhar; Andrew G Renehan; Damian Mullan; Bipasha Chakrabarty; Mark P Saunders; Bernadette M Carrington
Journal:  Eur Radiol       Date:  2016-04-18       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.